GetTopicDetailResponse(id=0caee6974ed, topicName=索拉珠單抗, introduction=索拉珠單抗, content=null, image=null, comments=1, allHits=480, url=https://h5.medsci.cn/topic?id=76974, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=95975, tagList=[TagDto(tagId=95975, tagName=索拉珠單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1804399, encodeId=0a29180439948, content=<a href='/topic/show?id=0caee6974ed' target=_blank style='color:#2F92EE;'>#索拉珠單抗#</a>, objectTitle=禮來表示沒有計劃重新審查其阿茲海默氏藥物索拉珠單抗已經(jīng)失敗的III期臨床實驗, objectType=article, longId=181882, objectId=a91918188212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a91918188212, replyNumber=0, likeNumber=73, createdTime=2020-09-14, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a91918188212, moduleTitle=禮來表示沒有計劃重新審查其阿茲海默氏藥物索拉珠單抗已經(jīng)失敗的III期臨床實驗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a91918188212)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
